Person

Charles H. Hill

Formerly Executive Vice President, Pfizer

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$4.7M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • PFE
    Pfizer
    Executive Vice President
    2016 or earlier – last filing Mar 2018

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 6, 2018PFESale30,539$35.78$1.1M
Mar 6, 2018PFESale10,715$35.70$383K
Mar 6, 2018PFESale493$35.79$18K
Mar 6, 2018PFESale330$35.80$12K
Mar 6, 2018PFESale316$35.81$11K
Feb 28, 2018PFESale17,079$36.83$629K
Feb 28, 2018PFESale1,100$36.84$41K
Feb 28, 2018PFESale5,400$36.82$199K
Feb 28, 2018PFESale3,200$36.85$118K
Mar 9, 2017PFESale36,000$34.07$1.2M
May 9, 2016PFESale28,300$33.84$958K
May 9, 2016PFESale1,300$33.83$44K

SEC reporting-owner ID (CIK) 1508517 · all filings on EDGAR